Edwards Lifesciences Corporation (EW)
BMV
Closed
Aug 21, 2026
Day's Range
1,577.0052 wk Range
1,340.70Overview - EW - Edwards Lifesciences Corporation
Key Statistics
Valuation
Enterprise Value
1.27T
P/E (Trailing)
‪75.92‬
PEG Ratio
‪-2.88‬
Price / Sales (TTM)
‪210.39‬
Price / Book
‪116.46‬
EV / EBITDA
‪648.59‬
Profitability
Gross Margin
‪77.46%‬
Profit Margin
‪78.01%‬
Operating Margin
‪21.31%‬
Return on Assets
‪7.83%‬
Return on Equity
‪10.38%‬
Ownership
Shares Outstanding
576.60M
Price stats
50-Day Avg
‪1,537.91‬
200-Day Avg
‪1,485.67‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - EW - Edwards Lifesciences Corporation
Peers - EW - Edwards Lifesciences Corporation
Peer Comparison
Compared with companies in Medical Devices listed on BMV.
Profile Summary - EW - Edwards Lifesciences Corporation
About
Edwards Lifesciences Corporation is a leading global structural heart innovation company focused on advancing treatments for cardiovascular disease. The company specializes in developing and providing innovative medical technologies for structural heart conditions, including transcatheter heart valves that enable…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
